Trevi Therapeutics Inc (TRVI)

SG&A Expense Growth

7.77%

Quarterly · Period ending:

TRVI logo

TRVI SG&A Expense Growth

Latest reported7.77%
TRVI Quarterly SG&A Growth (QoQ) (0.00% → 7.77%)
High-resolution chart · PNG

TRVI sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Trevi Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
7.765%
23.4418%
5.1162%
-11.5855%
18.4203%
27.1811%
0.489%
-11.3622%
5.3146%
28.8655%
-12.5643%
7.1654%
-0.8974%
9.5299%
-11.2291%
-2.9812%
14.1597%
13.6581%
-6.0565%
-16.4856%
6.76%
-5.0513%
8.9818%
-3.0498%
-4.8855%
34.843%
-2.85%
5.8761%
28.1547%
4.8364%
16.1983%
28.5866%
20.7959%
24.8397%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.